RecruitingNot Applicable

Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.

Egypt200 participantsStarted 2025-07-11

Plain-language summary

Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis

Who can participate

Age range9 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Permanent Molar with closed Apex and diagnosed with irreversible pulpitis \- Exclusion Criteria: * medically compromised children. * non restorable tooth * Necrotic tooth

What they're measuring

Clinical evaluation of cases using visual analogue scale, electrical pulp testing, Sensibility testing using both hot and cold and Percussion test for the teeth

Timeframe: 12 months

Radiographic evaluation of sucess of concentrated Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar with irreversible pulpitis

Timeframe: 12 months

Trial details

NCT IDNCT07138287

SponsorMinia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-01

Contact for this trial

Mahmoud Mostafa Abdelhakim, Master degree

201004445513 mahmoudmostafa100001@gmail.com

View on ClinicalTrials.gov More Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis trials